(SXRZ) iShares VII - iShares - Ratings and Ratios
Japanese Stocks, Nikkei Index, Large Cap Equities
Description: SXRZ iShares VII - iShares
The iShares Nikkei225 ETF JPY Acc (SXRZ) is an exchange-traded fund listed on XETRA, tracking the Morningstar Japan TME NR JPY Index. As a Japan Large-Cap Blend Equity ETF, it provides investors with exposure to the Japanese equity market, focusing on large-cap stocks.
With Assets Under Management (AUM) of approximately €58.145 billion, SXRZ is a substantial investment vehicle, indicating significant investor interest in the Japanese market. The funds size suggests it has sufficient liquidity, making it easier for investors to enter or exit positions without significantly impacting the market price.
To evaluate the performance of SXRZ, we can look beyond the technical data. Key Performance Indicators (KPIs) such as the expense ratio, tracking error, and dividend yield can provide valuable insights. Although the expense ratio is not provided, its essential to consider it as it directly affects the net returns to investors. A lower expense ratio is generally more favorable. The tracking error, which measures the deviation of the funds returns from its benchmark, is another crucial metric. A low tracking error indicates that the ETF is effectively replicating the performance of the Morningstar Japan TME NR JPY Index.
Investors should also consider the funds dividend yield, which can contribute to its total return. For a JPY-denominated ETF like SXRZ, currency fluctuations can impact returns for investors not based in Japan. Understanding the composition of the fund, including sector allocation and top holdings, can help investors assess its risk profile and potential for growth.
Overall, the iShares Nikkei225 ETF JPY Acc offers a diversified investment in the Japanese large-cap equity market. By examining relevant KPIs and understanding the funds characteristics, investors can make more informed decisions about its suitability for their investment portfolios.
Additional Sources for SXRZ ETF
SXRZ ETF Overview
Market Cap in USD | 64,150m |
Category | Japan Large-Cap Blend Equity |
TER | 0.48% |
IPO / Inception | 2010-01-25 |
SXRZ ETF Ratings
Growth Rating | 30.3 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -20.1 |
Analysts | - |
Fair Price Momentum | 206.61 EUR |
Fair Price DCF | - |
SXRZ Dividends
Currently no dividends paidSXRZ Growth Ratios
Growth Correlation 3m | 42.2% |
Growth Correlation 12m | -17.1% |
Growth Correlation 5y | 58.5% |
CAGR 5y | 6.92% |
CAGR/Max DD 5y | 0.32 |
Sharpe Ratio 12m | -0.08 |
Alpha | -6.12 |
Beta | 0.921 |
Volatility | 18.92% |
Current Volume | 0.8k |
Average Volume 20d | 0.6k |
Stop Loss | 233.2 (-3%) |
As of July 31, 2025, the stock is trading at EUR 240.45 with a total of 848 shares traded.
Over the past week, the price has changed by -1.68%, over one month by +0.04%, over three months by +7.25% and over the past year by +4.75%.
Neither. Based on ValueRay´s Analyses, iShares VII - iShares is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 30.25 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SXRZ is around 206.61 EUR . This means that SXRZ is currently overvalued and has a potential downside of -14.07%.
iShares VII - iShares has no consensus analysts rating.
According to our own proprietary Forecast Model, SXRZ iShares VII - iShares will be worth about 247.9 in July 2026. The stock is currently trading at 240.45. This means that the stock has a potential upside of +3.11%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 247.9 | 3.1% |